Latest filing published 18 Sept 2023 for Swedish Orphan Biovitrum AB (publ), €34k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Helena Saxon: trading record in brief
Helena Saxon appears in our data through filings on Swedish Orphan Biovitrum AB (publ) shares, published by Finansinspektionen. Over a trading history stretching from 5 March 2021 to 14 September 2023, the count stands at 3 filings.
Both buying and selling appear: 1 purchase worth €61k, against 1 sale worth €6. On balance, insiders were net buyers of €61k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2023 to date brings no purchases and 1 sale.
The record was last updated on 18 September 2023 with a transaction (€34k) in Swedish Orphan Biovitrum AB (publ). The latest purchase dates back some time: it was published 2,075 days ago, on 5 March 2021. Filings reach the Finansinspektionen feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Helena Saxon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,856 shares@ SEK 142.0035.9% of flowBTA (betald tecknad aktie)ISIN SE0020846293FI:csv-06aa9e287ff8b445f9ec
- 6 shares@ SEK 11.19170.0% of flowTeckningsrätt/UniträttISIN SE0020846285FI:csv-76e221db7dafa8838d1f
- 4,500 shares@ SEK 137.60100.0% of flowAktieISIN SE0000872095FI:A001Q983-1Canonical exit: 3 Jun 2021 (T+90)
3 of 3 declarations